Advertisement
Screener

REGENCY CENTERS CORPORATION (REG) Spending and interest coverage

REGENCY CENTERS CORPORATION (REG) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
  • Stock-based compensation / revenue · 12 months: Value 1.25%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-03-31.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months1.25%Share-based compensation / revenue. Period ending 2026-03-31.

$19.77M ÷ $1.59B × 100 ≈ 1.25%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue1.59B USD
Stock-based compensation19.77M USDShare-based Payment Arrangement, Noncash Expense
Operating income1.15B USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-03-31(m)$1.59B$19.77M$1.15B(m)(m)1.25%(m)(m)
2025-12-31(m)$1.55B$19.46M$1.12B(m)(m)1.25%(m)(m)
2025-09-30(m)$1.52B$19.49M$1.10B(m)(m)1.28%(m)(m)
2025-06-30(m)$1.49B$20.83M$1.08B(m)(m)1.39%(m)(m)
2025-03-31(m)$1.47B$22.18M$1.06B(m)(m)1.51%(m)(m)
2024-12-31(m)$1.45B$23.50M$1.05B(m)(m)1.62%(m)(m)
2024-09-30(m)$1.44B$24.70M(m)(m)(m)1.71%(m)(m)
2024-06-30(m)$1.41B$23.76M(m)(m)(m)1.68%(m)(m)
2024-03-31(m)$1.37B$21.56M(m)(m)(m)1.58%(m)(m)
2023-12-31(m)$1.32B$20.07M(m)$154.25M(m)1.52%(m)Reported
2023-09-30(m)$1.28B$18.13M(m)$148.54M(m)1.42%(m)Reported
2023-06-30(m)$1.25B$16.87M(m)$146.10M(m)1.35%(m)Reported
2023-03-31(m)$1.24B$17.17M(m)$145.84M(m)1.39%(m)Reported
2022-12-31(m)$1.22B$16.52M(m)$146.19M(m)1.35%(m)Reported
2022-09-30(m)$1.21B$15.84M(m)$146.23M(m)1.31%(m)Reported
2022-06-30(m)$1.21B$15.12M(m)$145.86M(m)1.25%(m)Reported
2022-03-31(m)$1.19B$14.26M(m)$144.97M(m)1.19%(m)Reported
2021-12-31(m)$1.17B$12.52M(m)$145.17M(m)1.07%(m)Reported
2021-09-30(m)$1.13B$12.20M(m)$146.81M(m)1.08%(m)Reported
2021-06-30(m)$1.06B$12.26M(m)$151.62M(m)1.15%(m)Reported
2021-03-31(m)$1.01B$12.68M(m)$156.18M(m)1.26%(m)Reported
2020-12-31(m)$1.02B$13.58M(m)$156.68M(m)1.34%(m)Reported
2020-09-30(m)$1.05B$14.28M(m)$156.69M(m)1.36%(m)Reported
2020-06-30(m)$1.09B$14.57M(m)$154.15M(m)1.34%(m)Reported
2020-03-31(m)$1.13B$14.18M(m)$150.95M(m)1.25%(m)Reported
2019-12-31(m)$1.13B$14.34M(m)$151.26M(m)1.27%(m)Reported
2019-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31(m)$1.13B(m)(m)(m)(m)(m)(m)(m)
2018-12-31(m)$1.12B$13.63M(m)$148.46M(m)1.22%(m)Reported
2018-09-30(m)$1.10B(m)(m)(m)(m)(m)(m)(m)
2018-06-30(m)$1.08B(m)(m)(m)(m)(m)(m)(m)
2017-12-31(m)$984.33M$20.55M(m)$132.63M(m)2.09%(m)Reported
2015-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30(m)(m)$11.70M(m)(m)(m)(m)(m)(m)
2013-06-30(m)(m)$11.06M(m)(m)(m)(m)(m)(m)
2013-03-31(m)$473.78M(m)(m)(m)(m)(m)(m)(m)
2012-12-31(m)$496.92M$9.81M(m)(m)(m)1.97%(m)(m)
2012-09-30(m)$498.51M$9.79M(m)(m)(m)1.96%(m)(m)
2012-06-30(m)$501.50M$9.72M(m)(m)(m)1.94%(m)(m)
2011-12-31(m)$500.42M$9.82M(m)(m)(m)1.96%(m)(m)
2011-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-12-31(m)$476.16M$6.62M(m)(m)(m)1.39%(m)(m)
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-12-31(m)(m)$3.93M(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
MID AMERICA APARTMENT COMMUNITIES INC. (MAA)United States$13.645B36.48
SUN COMMUNITIES INC (SUI)United States$13.691B65.43
HEALTHPEAK PROPERTIES, INC. (DOC)United States$13.970B53.70
OMEGA HEALTHCARE INVESTORS INC (OHI)United States$14.039B15.94
WEYERHAEUSER CO (WY)United States$14.523B36.55
KIMCO REALTY CORP (KIM)United States$14.932B27.99
W. P. Carey Inc. (WPC)United States$15.027B25.03
EQUITY LIFESTYLE PROPERTIES INC (ELS)United States$11.551B30.33
HOST HOTELS & RESORTS, INC. (HST)United States$15.223B15.81
American Healthcare REIT, Inc. (AHR)United States$11.408B83.91